Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

This company has been marked as potentially delisted and may not be actively trading.

Clearside Biomedical (CLSD) Earnings Date, Estimates & Call Transcripts

Clearside Biomedical logo
Compare

Clearside Biomedical Earnings Summary

Clearside Biomedical posted Q3 2025 earnings on November 14, 2025, reporting an EPS of -$1.14, which missed the consensus estimate of -$0.67 by $0.47. Quarterly revenue was reported to be $0.20 million, above the consensus estimate of $0.09 million. With a trailing EPS of -$5.19, Clearside Biomedical's earnings are expected to decrease next year, from ($0.48) to ($0.50) per share.

Q3 2025 Earnings Resources

Powered by Quartr
Latest Q3
Earnings Date
Nov. 14Estimated
Consensus EPS
(Nov. 14)
-$0.67
Actual EPS
(Nov. 14)
-$1.14 Missed By -$0.47
Actual Revenue
(Nov. 14)
$0.20M
Get Clearside Biomedical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clearside Biomedical and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CLSD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLSD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Clearside Biomedical Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.48) EPS
Next Year EPS Consensus Estimate
($0.50) EPS

Clearside Biomedical Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/14/2025Q3 2025-$0.67-$1.14 -$0.47-$1.14$0.09M$0.20M
8/8/2025Q2 2025-$1.80-$0.90+$0.90-$0.06$0.50M$0.49M
5/14/2025Q1 2025-$1.80-$1.65+$0.15-$0.11$0.20M$2.33M
3/27/2025Q4 2024-$1.95-$1.50+$0.45-$0.10$0.27M$0.31M
11/12/2024Q3 2024-$2.10-$1.50+$0.60-$0.10$0.25M$1.04M
8/12/2024Q2 2024-$2.10-$1.50+$0.60-$0.10$0.25M$0.09M

Data powered by Fiscal.ai.

Clearside Biomedical Earnings - Frequently Asked Questions

Clearside Biomedical (NASDAQ:CLSD) last announced its quarterly earning data on Friday, November 14, 2025. Learn more on CLSD's earnings history.

In the previous quarter, Clearside Biomedical (NASDAQ:CLSD) missed the analysts' consensus estimate of ($0.67) by $0.47 with a reported earnings per share (EPS) of ($1.14). Learn more on analysts' earnings estimate vs. CLSD's actual earnings.

Clearside Biomedical (NASDAQ:CLSD) has a recorded annual revenue of $3.33 million.

Clearside Biomedical (NASDAQ:CLSD) has a recorded net income of -$34.35 million. CLSD has generated -$5.19 earnings per share over the last four quarters.

Clearside Biomedical's earnings are expected to decrease from ($0.48) per share to ($0.50) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:CLSD) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
The AI stocks about to become worthless (and one that isn't)
Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...
InvestorPlace | Sponsoredtc pixel